Lv51
1510 积分 2024-08-27 加入
Endothelin System Blockade Extenuates Sepsis‐Induced Acute Heart and Kidney Injuries via Modulating ET‐1/Klotho/p38‐MAPK
1小时前
已完结
Inhibition of p75NTR/p53 axis by ambrisentan suppresses apoptosis and oxidative stress-mediated renal damage in a cisplatin AKI model
9小时前
已完结
Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials
2个月前
已完结
The Endothelin System and Its Antagonism in Chronic Kidney Disease
2个月前
已关闭
Endothelin-A Receptor Antagonism Modifies Cardiovascular Risk Factors in CKD
2个月前
已完结
Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease
2个月前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
2个月前
已完结
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD
2个月前
已完结
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease
2个月前
已完结
Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial
2个月前
已完结
皖公网安备34019202002308
